MYMETICS-LED CONSORTIUM AWARDED €8.4 MILLION FOR DEVELOPMENT OF THERMO STABLE AND COLD-CHAIN INDEPENDENT VACCINES

Of the total amount, €3.4 million is directly attributable to Mymetics activities, with the balance going to the consortium partners, Catalent UK Swindon Zydis Ltd, Chimera Biotec GmbH (Germany), Upperton Ltd. (UK) and Bachem AG (Switzerland).

more